Comments
Loading...
Renovaro (RENB) Forecast
NewsEarningsRenovaro (RENB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB | Benzinga
Explore Renovaro stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RENB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Renovaro (RENB) stock?
You can purchase shares of Renovaro (NASDAQ:RENB) through any online brokerage.
Who are Renovaro (RENB) competitors?
Other companies in Renovaro’s space includes: Zura Bio (NASDAQ:ZURA), Serina Therapeutics (AMEX:SER), Connect Biopharma Hldgs (NASDAQ:CNTB), Armata Pharmaceuticals (AMEX:ARMP) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Renovaro (RENB) stock?
There is no analysis for Renovaro to provide a consensus price target.
What is the current price for Renovaro (RENB)?
The stock price for Renovaro (NASDAQ: RENB) is $0.362 last updated June 24, 2025 at 12:19 PM EDT.
Does Renovaro (RENB) pay a dividend?
There are no upcoming dividends for Renovaro.
When is Renovaro (NASDAQ:RENB) reporting earnings?
Renovaro’s Q3 earnings are confirmed for Thursday, May 15, 2025.
Is Renovaro (RENB) going to split?
There is no upcoming split for Renovaro.
What sector and industry does Renovaro (RENB) operate in?
Renovaro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
